GEORGETOWN LOMBARDI COMPREHENSIVE CANCER CENTER and JOHN THEURER CANCER CENTER formed an immunotherapy research collaboration.
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO is encouraging cancer researchers to recruit more Hispanics in clinical trials to reduce health disparities.
THE NATIONAL PATIENT ADVOCATE FOUNDATION has launched Project Innovation, a movement to accelerate the pace of cancer medical discovery and to get therapies to patients quickly.
MAURIE MARKMAN was named president of the Medicine & Science unit of the Cancer Treatment Centers of America.
THE JOHNS HOPKINS UNIVERSITY received a $15 million pledge to help create a new bladder cancer institute.
A Kansas City, Kan., cancer clinic agreed to pay $2.9 million to resolve allegations that it violated the False Claims Act by submitting claims to Medicare, Medicaid, and the Federal Employee Health Benefits Program without providing those drugs and services.
The word “alternative” may soon disappear from the name of the NIH National Center for Complementary and Alternative Medicine.
My name is Clifford Hudis, and I am a medical oncologist at Memorial Sloan Kettering Cancer Center where I am chief of the Breast Medicine Service. I am also professor of medicine at the Weill Cornell Medical College and president of ASCO. I have had an amazing year serving as the president of ASCO, and today I am delighted to welcome you to our society's 50th annual meeting commemorated in recent weeks by both the Congress of the United States and also by our host city, Chicago, and its Mayor, Mr. Rahm Emanuel.
Four Options in Colorectal CancerAnother practice-changing study—CALGB/SWOG 80405— sought to determine whether there is an optimal first-line treatment for patients with untreated metastatic colorectal cancer without KRAS mutations by comparing chemotherapy plus either bevacizumab or cetuximab.
CHICAGO—The consequences of diminishing federal support for cancer research can be measured in the abstracts presented at the 50th annual meeting of the American Society of Clinical Oncology that concluded earlier this week.
